US 11622547
Genetically modified mouse that expresses human albumin
granted A61KA61K49/0008
Quick answer
US patent 11622547 (Genetically modified mouse that expresses human albumin) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K49/0008